Ending Medicare Part D Premium Subsidy Program After 2026
On July 28, the U.S. Centers for Medicare & Medicaid Services (CMS) announced that the Trump administration will terminate the subsidy program helping stabilize insurance premium costs for Medicare Part D prescription drug plans after 2026. According to CMS, through an evaluation of premium rate proposals from insurers for 2027, they found that providers have accumulated enough experience to accurately price insurance plans without support from this subsidy program.
Dr. Mehmet Oz, CMS administrator, posted on X that: 'We are stabilizing the market, so this subsidy is no longer necessary. Premium costs are expected to increase by less than $10 for most Medicare recipients, while many others may see lower premium costs.'
Crucial Role of Medicare Part D and Impact on the Elderly
Medicare Part D is a prescription drug insurance program for millions of beneficiaries through private insurance plans. It is an important part of the federal healthcare system for the elderly in the United States.












